series-b
Stage
4
Investors
About
LightOx develops light-activated drug compounds for treating early-stage oral cancers and other diseases, using photosensitizing agents activated by light to target cancer cells.
Explore Lightox Limited's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.